RT Journal Article
T1 Superinfection during treatment of nosocomial infections with tigecycline
A1 García-Cabrera, Emilio
A1 Jiménez-Mejías, Manuel E.
A1 Gil-Navarro, María Victoria
A1 Gómez-Gómez, M J
A1 Ortiz-Leyba, C
A1 Cordero, Elisa
A1 Pachón, J
K1 Minimum Inhibitory Concentration
K1 Nosocomial Infection
K1 Tigecycline
K1 Acinetobacter Baumannii
K1 Stenotrophomonas Maltophilia
AB We performed a retrospective and observational study of 51 patients treated with tigecycline, as the treatment for nosocomial infections due to multidrug-resistant microorganisms, to evaluate the superinfection rate and their etiologies. Superinfections were diagnosed in 12 (23.5%) patients (seven due to Pseudomonas aeruginosa, 13.7%) and one patient had P. aeruginosa colonization. Five patients with superinfection died (41.6%), three due to superinfections and two to underlying diseases. The superinfection rate observed during tigecycline treatment is higher than that previously reported. Pseudomonas aeruginosa is the most frequent agent, being the cause of 58.5% of all superinfections.
PB Springer
SN 2732-5326
YR 2010
FD 2010-05-16
LK https://hdl.handle.net/10668/28450
UL https://hdl.handle.net/10668/28450
LA en
NO García-Cabrera E, Jiménez-Mejías ME, Gil Navarro MV, Gómez-Gómez MJ, Ortiz-Leyba C, Cordero E, et al Superinfection during treatment of nosocomial infections with tigecycline. Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):867-7081
NO This study was supported by the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008, Instituto de Salud Carlos III-FEDER, Ministerio de Ciencia e Innovación).
DS RISalud
RD Apr 9, 2025